Use of Terlipressin in Cirrhosis With Ascites: A Questionnaire Survey in China

被引：1
|
作者：
Bai, Zhaohui [1 ,2 ]
Li, Hongyu [1 ]
Guo, Xiaozhong [1 ]
Qi, Xingshun [1 ]
机构：
[1] Gen Hosp, Northern Theater Command, Dept Gastroenterol, 83 Wenhua Rd, Shenyang 110840, Liaoning, Peoples R China
[2] Shenyang Pharmaceut Univ, Postgrad Coll, Shenyang 110840, Peoples R China
来源：
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY | 2020年 / 10卷 / 04期
关键词：
REFRACTORY ASCITES; DYSFUNCTION; ALBUMIN;
D O I：
10.1016/j.jceh.2019.11.010
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：407 / 408
页数：2
相关论文
共 50 条
  • [31] Effective palliation of refractory ascites in cirrhosis is challenging
    Abbott, Jane
    Verma, Sumita
    Saksena, Sushma
    INTERNATIONAL JOURNAL OF PALLIATIVE NURSING, 2024, 30 (06) : 286 - 293
  • [32] Terlipressin-Induced Peripheral Cyanosis in a Patient with Liver Cirrhosis and Hepatorenal Syndrome
    Chiang, Chi-Wen
    Lin, Yun-Ju
    Huang, Yaw-Bin
    AMERICAN JOURNAL OF CASE REPORTS, 2019, 20 : 5 - 9
  • [33] Cell-free and Concentrated Ascites Reinfusion Therapy for Refractory Ascites in Cirrhosis in Post-marketing Surveillance and the Role of Tolvaptan
    Iwasa, Motoh
    Ishihara, Tomoaki
    Kato, Michio
    Isoai, Ayako
    Kobayashi, Ryosuke
    Torii, Naoko
    Soneda, Noriko
    Takei, Yoshiyuki
    INTERNAL MEDICINE, 2019, 58 (21) : 3069 - 3075
  • [34] Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites
    Piano, Salvatore
    Rosi, Silvia
    Maresio, Giulio
    Fasolato, Silvano
    Cavallin, Marta
    Romano, Antonietta
    Morando, Filippo
    Gola, Elisabetta
    Frigo, Anna Chiara
    Gatta, Angelo
    Angeli, Paolo
    JOURNAL OF HEPATOLOGY, 2013, 59 (03) : 482 - 489
  • [35] Liver Cirrhosis and hepatorenal Syndrome: The Response to Terlipressin and Albumin is associated with better Survival
    Nguyen-Tat, M.
    Goetz, E.
    Scholz-Kreisel, P.
    Ahrens, J.
    Sivanathan, V.
    Schattenberg, J.
    Rey, J. W.
    Woerns, M. -A.
    Galle, P. R.
    Marquardt, J. U.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (02) : E21 - E26
  • [36] Cell-Free and Concentrated Ascites Reinfusion Therapy for Decompensated Liver Cirrhosis
    Kozaki, Koichi
    IInuma, Masahiro
    Takagi, Tomoyuki
    Fukuda, Takanori
    Sanpei, Takaya
    Terunuma, Yusuke
    Yatabe, Yoshiharu
    Akano, Kazuhiro
    THERAPEUTIC APHERESIS AND DIALYSIS, 2016, 20 (04) : 376 - 382
  • [37] The Use of Human Albumin for the Treatment of Ascites in Patients with Liver Cirrhosis: Item of Safety, Facts, Controversies and Perspectives
    Facciorusso, Antonio
    Nacchiero, Maurizio Cosimo
    Rosania, Rosa
    Laonigro, Giulio
    Longo, Nunzio
    Panella, Carmine
    Ierardi, Enzo
    CURRENT DRUG SAFETY, 2011, 6 (04) : 267 - 274
  • [38] Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence
    Bai, Zhaohui
    An, Yang
    Guo, Xiaozhong
    Teschke, Rolf
    Mendez-Sanchez, Nahum
    Li, Hongyu
    Qi, Xingshun
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2020, 2020
  • [39] Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: A randomized study
    Singh, V
    Kumar, R
    Nain, CK
    Singh, B
    Sharma, AK
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 (01) : 303 - 307
  • [40] Beta-Blockers in Cirrhosis Patients With Refractory Ascites
    Robins, Anne
    Bowden, Anne
    Watson, William
    Smith, Fiona
    Gelson, William
    Griffiths, William
    HEPATOLOGY, 2014, 59 (05) : 2054 - 2055
12345